Trials / Completed
CompletedNCT05194371
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, data of esophageal cancer patients undergoing definitive radiotherapy in 14 institutions from various provinces in China were evaluated to help strengthen confidence in anti-cancer, including rehabilitation, economic burden, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | definitive radiotherapy or definitive chemoradiotherapy | A total dose of radiation therapy should be more than 50Gy |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2021-10-31
- Completion
- 2021-12-15
- First posted
- 2022-01-18
- Last updated
- 2022-01-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05194371. Inclusion in this directory is not an endorsement.